Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway
Astragalus propinquus Schischkin and Salvia miltiorrhiza Bunge (AS) have been clinically used as adjunctive drugs in the treatment of myocardial ischemia (MI). However, the effect and mechanism of AS on MI have yet to be fully recognized. Here, we explored the cardioprotective effect of their combin...
Saved in:
Main Authors: | Mu-Xin Zhang (Author), Xue-Ying Huang (Author), Yu Song (Author), Wan-Li Xu (Author), Yun-Lun Li (Author), Chao Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of the mechanism of the anti-cancer effects of Astragalus propinquus Schischkin and Pinellia pedatisecta Schott (A&P) on melanoma via network pharmacology and experimental verification
by: Fang Wang, et al.
Published: (2022) -
Tanshinone IIA, a melanogenic ingredient basis of Salvia miltiorrhiza Bunge
by: Zhaojing Wang, et al.
Published: (2021) -
Salvianolic acid B from Salvia miltiorrhiza bunge: A potential antitumor agent
by: Sha-Sha Guo, et al.
Published: (2022) -
Salvia miltiorrhiza bunge extracts: a promising source for anti-atopic dermatitis activity
by: Da Hye Ryu, et al.
Published: (2024) -
Network pharmacology and experimental study of phenolic acids in salvia miltiorrhiza bung in preventing ischemic stroke
by: Chengdi Liu, et al.
Published: (2023)